GPC3 and hepatocellular carcinoma: In a recent study by Li et al. (2020), engineered T cells that express chimeric antigen receptors (CARs) consisting of humanized antibodies targeting GPC3 were administered to mice bearing xenografted tumors obtained through injecting Hep3B and HepG2 HCC cells.